Indaptus Therapeutics (INDP) stock
Breakaway doesn't score INDP. It is too thinly traded for a fair Quality Score.
Follow INDP's trial news. Pro members can get an alert when Indaptus Therapeutics files news, and see its trials, share raises, and its CEO's filings.
We do the work for you. 3,170 stocks are scored and ranked, every 15 seconds while the market is open. Pro members see it live.
What's next for INDP, and how long its cash lasts
Its trials
Cash runway
About 3 quarters
Dilution on the horizon
- Shelf registration (S-3, filed Aug 13, 2025)
- At-the-market share sales program (424B5, filed Aug 31, 2026)
Insiders
No open-market buys or sales by its officers or directors in their filings of the last year.
FDA dates in the next 60 days
Decision dates and advisory committee meetings the companies have announced in their filings, soonest first and small companies first.
INDP's latest filings
- Indaptus Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate Update
- Quarterly report
- Prospectus for a sale of securities
Why INDP isn't scored
The Quality Score reads US-listed stocks worth $50M or more that trade at $1 or more and 300,000 shares or $10M a day. INDP trades about 225,000 shares a day. A stock that clears every mark is scored from the next weekly rebuild.
Straight AnswersStraight Answers
Are the prices delayed?
Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.
Only on the public pages, which run at least 15 minutes behind. Pro members see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included. The one stock you open in full is live too.